To all:
Northfield Laboratories Reports Fiscal 2001 Third Quarter Results
Updated: Tuesday, April 17, 2001 08:15 AM
EVANSTON, Ill., April 17 /PRNewswire/ -- Northfield Laboratories Inc. (Nasdaq: NFLD, news, msgs), a leading developer of an oxygen-carrying blood substitute for trauma and elective surgery situations, reported a loss, as anticipated, for its third fiscal quarter ended February 28, 2001. As a development-stage company, Northfield has no revenues.
For the third quarter, Northfield reported a loss of $2.6 million, or $0.18 cents per basic share compared with a loss of $2.5 million, or $0.17 cents per basic share, in the year-earlier period. For the latest nine months, net loss was $7.4 million, or $0.52 cents per basic share compared with a loss of $6.8 million, or $0.48 cents per basic share, in the first nine months of fiscal 2000.
quicken.com
Chuck |
